Research ExplorerPublicationsExpression and prognostic relevance of annexin A3 in prostat...

Expression and prognostic relevance of annexin A3 in prostate cancer.

Standard

Expression and prognostic relevance of annexin A3 in prostate cancer. / Köllermann, Jens; Schlomm, Thorsten; Bang, Holger; Schwall, Gerhard P; von Eichel-Streiber, Christoph; Simon, Ronald; Schostak, Martin; Huland, Hartwig; Berg, Wigbert; Sauter, Guido; Klocker, Helmut; Schrattenholz, André.

In: EUR UROL, Vol. 54, No. 6, 6, 2008, p. 1314-1323.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Köllermann, J, Schlomm, T, Bang, H, Schwall, GP, von Eichel-Streiber, C, Simon, R, Schostak, M, Huland, H, Berg, W, Sauter, G, Klocker, H & Schrattenholz, A 2008, 'Expression and prognostic relevance of annexin A3 in prostate cancer.', EUR UROL, vol. 54, no. 6, 6, pp. 1314-1323. <http://www.ncbi.nlm.nih.gov/pubmed/18222597?dopt=Citation>

APA

Köllermann, J., Schlomm, T., Bang, H., Schwall, G. P., von Eichel-Streiber, C., Simon, R., Schostak, M., Huland, H., Berg, W., Sauter, G., Klocker, H., & Schrattenholz, A. (2008). Expression and prognostic relevance of annexin A3 in prostate cancer. EUR UROL, 54(6), 1314-1323. [6]. http://www.ncbi.nlm.nih.gov/pubmed/18222597?dopt=Citation

Vancouver

Köllermann J, Schlomm T, Bang H, Schwall GP, von Eichel-Streiber C, Simon R et al. Expression and prognostic relevance of annexin A3 in prostate cancer. EUR UROL. 2008;54(6):1314-1323. 6.

Bibtex

@article{18ad0ce007d8486e8e45cd3d3f6656b0,
title = "Expression and prognostic relevance of annexin A3 in prostate cancer.",
abstract = "OBJECTIVES: By differential quantitative protein expression, it has previously been shown that annexin A3 (ANXA3) expression is associated with prostate cancer. However little is known about the role and biology of ANXA3 in the human prostate. The aim of this study was to thoroughly analyze ANXA3 expression patterns and its potential as a prognostic marker in a large set of benign, preneoplastic, and neoplastic prostate tissue samples. METHODS: Immunohistochemistry-based ANXA3 protein expression was analyzed for 1589 prostate cancers as well as smaller subsets of benign epithelium and high-grade prostatic intraepithelial neoplasia (PIN) in a tissue microarray format. RESULTS: All samples of benign prostatic epithelium and PIN showed ANXA3 protein expression, with PIN lesions showing a decreased staining intensity compared with benign epithelium (p",
author = "Jens K{\"o}llermann and Thorsten Schlomm and Holger Bang and Schwall, {Gerhard P} and {von Eichel-Streiber}, Christoph and Ronald Simon and Martin Schostak and Hartwig Huland and Wigbert Berg and Guido Sauter and Helmut Klocker and Andr{\'e} Schrattenholz",
year = "2008",
language = "Deutsch",
volume = "54",
pages = "1314--1323",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "6",

}

RIS

TY - JOUR

T1 - Expression and prognostic relevance of annexin A3 in prostate cancer.

AU - Köllermann, Jens

AU - Schlomm, Thorsten

AU - Bang, Holger

AU - Schwall, Gerhard P

AU - von Eichel-Streiber, Christoph

AU - Simon, Ronald

AU - Schostak, Martin

AU - Huland, Hartwig

AU - Berg, Wigbert

AU - Sauter, Guido

AU - Klocker, Helmut

AU - Schrattenholz, André

PY - 2008

Y1 - 2008

N2 - OBJECTIVES: By differential quantitative protein expression, it has previously been shown that annexin A3 (ANXA3) expression is associated with prostate cancer. However little is known about the role and biology of ANXA3 in the human prostate. The aim of this study was to thoroughly analyze ANXA3 expression patterns and its potential as a prognostic marker in a large set of benign, preneoplastic, and neoplastic prostate tissue samples. METHODS: Immunohistochemistry-based ANXA3 protein expression was analyzed for 1589 prostate cancers as well as smaller subsets of benign epithelium and high-grade prostatic intraepithelial neoplasia (PIN) in a tissue microarray format. RESULTS: All samples of benign prostatic epithelium and PIN showed ANXA3 protein expression, with PIN lesions showing a decreased staining intensity compared with benign epithelium (p

AB - OBJECTIVES: By differential quantitative protein expression, it has previously been shown that annexin A3 (ANXA3) expression is associated with prostate cancer. However little is known about the role and biology of ANXA3 in the human prostate. The aim of this study was to thoroughly analyze ANXA3 expression patterns and its potential as a prognostic marker in a large set of benign, preneoplastic, and neoplastic prostate tissue samples. METHODS: Immunohistochemistry-based ANXA3 protein expression was analyzed for 1589 prostate cancers as well as smaller subsets of benign epithelium and high-grade prostatic intraepithelial neoplasia (PIN) in a tissue microarray format. RESULTS: All samples of benign prostatic epithelium and PIN showed ANXA3 protein expression, with PIN lesions showing a decreased staining intensity compared with benign epithelium (p

M3 - SCORING: Zeitschriftenaufsatz

VL - 54

SP - 1314

EP - 1323

JO - EUR UROL

JF - EUR UROL

SN - 0302-2838

IS - 6

M1 - 6

ER -